We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$16.3M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.26M
3
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$3.76M
4
SIVB
SVB Financial Group
SIVB
+$3.69M
5
AAPL icon
Apple
AAPL
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
1701
Travere Therapeutics
TVTX
$5.79B
$70K ﹤0.01%
3,127
– –
VECO icon
1702
Veeco
VECO
$3.28B
$70K ﹤0.01%
4,143
– –
TPC
1703
Tutor Perini Cor
TPC
$4.98B
$70K ﹤0.01%
3,186
– –
RVNC
1704
DELISTED
Revance Therapeutics, Inc.
RVNC
$70K ﹤0.01%
2,272
+303
+15% +$9.75K
EXTN
1705
DELISTED
Exterran Corporation
EXTN
$70K ﹤0.01%
2,624
– –
NTRI
1706
DELISTED
NutriSystem, Inc.
NTRI
$70K ﹤0.01%
2,608
– –
BATRK icon
1707
Atlanta Braves Holdings Series B
BATRK
$3.41B
$69K ﹤0.01%
3,012
– –
MGNX icon
1708
MacroGenics
MGNX
$259M
$69K ﹤0.01%
2,753
– –
ATRI
1709
DELISTED
Atrion Corp
ATRI
$69K ﹤0.01%
110
– –
AYX
1710
DELISTED
Alteryx Inc
AYX
$69K ﹤0.01%
2,010
– –
JAG
1711
DELISTED
Jagged Peak Energy Inc.
JAG
$69K ﹤0.01%
4,878
– –
ALDR
1712
DELISTED
Alder Biopharmaceuticals
ALDR
$69K ﹤0.01%
5,401
– –
BHVN
1713
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$69K ﹤0.01%
2,682
+1,804
+205% +$53.9K
AMC icon
1714
AMC Entertainment Holdings
AMC
$2.35B
$68K ﹤0.01%
485
– –
ASMB icon
1715
Assembly Biosciences
ASMB
$594M
$68K ﹤0.01%
115
+12
+12% +$7.44K
CEVA icon
1716
CEVA Inc
CEVA
$855M
$68K ﹤0.01%
1,882
– –
NBHC icon
1717
National Bank Holdings
NBHC
$1.94B
$68K ﹤0.01%
2,041
– –
PFBC icon
1718
Preferred Bank
PFBC
$1.28B
$68K ﹤0.01%
1,057
– –
LMNX
1719
DELISTED
Luminex Corp
LMNX
$68K ﹤0.01%
3,221
– –
DF
1720
DELISTED
Dean Foods Company
DF
$68K ﹤0.01%
7,914
-27,278
-78% -$269K
ALRM icon
1721
Alarm.com
ALRM
$2.74B
$67K ﹤0.01%
1,783
– –
CUBI icon
1722
Customers Bancorp
CUBI
$2.82B
$67K ﹤0.01%
2,287
– –
GTY
1723
Getty Realty Corp
GTY
$2.05B
$67K ﹤0.01%
2,646
– –
HLX icon
1724
Helix Energy Solutions
HLX
$1.49B
$67K ﹤0.01%
11,574
– –
IRT icon
1725
Independence Realty Trust
IRT
$4.01B
$67K ﹤0.01%
7,263
– –
67 68
69
70 71

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.